High Surgical Risk Aortic Regurgitation: New TAVR Alternatives
11 min.
Moderate AS With Heart Failure: UNLOAD and Beyond
9 min.
Managing Heart Failure in AS With Multivalve Disease
10 min.
Low Flow - Low Gradient AS and Assessing Myocardial Reserve
15 min.
Recurrent Heart Failure After AVR: Causes and Treatment
8 min.
AS Reclassified According to Valve Function and Cardiac Disease
11 min.
Why Long-Term Valve Performance Matter
11 min.
Lifetime Management of Aortic Stenosis: The Importance of Choosing the First Valve
16 min.
Position 3: TAVR With a Supra-Annular Valve
6 min.
Position 2: TAVR With an Annular Valve
7 min.
Position 1: SAVR With Root Enlargement
10 min.
Considerations for Physiologic Testing to Assess CAD Severity in Patients With AS
8 min.
Case-Based Approach to Patients With Severe AS and MR (Degenerative and Functional)
11 min.
Moderate AS With ‘At Risk Features: The EXPAND TAVR II Trial
9 min.
SPOTLIGHT LECTURE Staging of Aortic Stenosis According to Cardiac Dysfunction: Recent Updates
17 min.
Moderate AS With ‘At Risk’ Features: The PROGRESS Trial
5 min.
UPSTREAM Aortic Stenosis Management: Conceptual Framework
9 min.
How Do We Communicate Known vs Uncertain Risks and Benefits of TAVR to Younger (<65 yo) Patients?
14 min.
Minimalist TAVR in 2023: Practical Tips and Tricks for a Safer, Less Invasive Procedure
16 min.
TAVR With the Self-Expanding EVOLUT FX: Procedural Technique With Case Examples
11 min.
TAVR With the Balloon-Expandable SAPIEN 3 Ultra: Procedural Techniques With Case Examples
9 min.
Bioskills: Understanding the Aortic Valve Anatomy and the Iteration with TAVR Devices
32 min.
Bioprosthetic Valve Failure and Durability—Does TAVR Really Outperform SAVR?
8 min.
A 70 Year-old Low-risk Woman With Asymptomatic Severe Aortic Stenosis : How Will Emerging Evidence Help Us?
3 min.
A 70 Year-old Low-risk Woman With Asymptomatic Severe Aortic Stenosis: What Do the Guidelines Say?
4 min.
Patient Prosthesis Mismatch After TAVR – Does Valve Selection Matter in the Small Annulus?
8 min.
Management of Concomitant Coronary Disease in AVR-Eligible Patients – COMPLEAT or NOT?
9 min.
Cerebral Embolic Protection: Why, When, and Who?
7 min.
Expanding TAVR to Moderate Aortic Stenosis: The Next Frontier?
7 min.
Optimal Anti-Thrombotic Therapy After TAVR – Updates and Controversies
10 min.
The Importance of Pre-emptive TAVR in the Future Management of Aortic Stenosis
13 min.
PENDING - CT-Guided ADR in a Calcium-Free LAD CTO Segment in a Post-TAVI/Post-CABG Patient
6 min.